Position in PBYI
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$187,527
-$93,145 QoQ
Shares Held
29,347
-37.8% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 24%
Shared 76%
None 0%
Common Shares in PBYI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026VIRTUS ADVISERS, LLC holds $9,774,150 across 19 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ACAD |
Acadia Pharmaceuticals Inc
|
44,384 | $1,122,914 | |
| 2 | HRMY |
Harmony Biosciences Holdings, Inc.
|
29,253 | $1,065,101 | |
| 3 | EXEL |
Exelixis, Inc.
|
14,769 | $803,581 | |
| 4 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
9,249 | $753,885 | |
| 5 | INVA |
Innoviva, Inc.
|
30,614 | $695,243 | |
| 6 | VCEL |
Vericel Corp
|
15,570 | $692,709 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
18,007 | $637,267 | |
| 8 | SRPT |
Sarepta Therapeutics, Inc.
|
27,098 | $486,950 |
All Filings in PBYI
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $187,527 | 29,347 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $280,672 | 47,172 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $250,483 | 47,172 | Shares | Other | 2026-02-13 | |
| 2025-06-30 | $190,128 | 55,431 | Shares | Other | 2026-02-13 | |
| 2025-03-31 | $164,075 | 55,431 | Shares | Other | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||